BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 23321605)

  • 1. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
    Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
    Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
    Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
    PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC5B: a good target for future therapy in pulmonary fibrosis?
    Mahida R; Turner AM
    Thorax; 2013 May; 68(5):401. PubMed ID: 23329274
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
    Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
    JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
    Wu X; Li W; Luo Z; Chen Y
    Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
    Schwartz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
    van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
    Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
    Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
    Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC5B expression and location in surfactant protein C mutations in children.
    Liptzin DR; Watson AM; Murphy E; Kroehl ME; Dishop MK; Galambos C; Evans CM; Schwarz MI; Deterding RR; Schwartz DA
    Pediatr Pulmonol; 2015 Dec; 50(12):1270-6. PubMed ID: 25858779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
    Volkmann ER; Tashkin DP; Roth MD; Li N; Charles J; Mayes M; Kim G; Goldin J; Pourzand L; Clements PJ; Furst DE; Khanna D; Elashoff RM; Assassi S
    Semin Arthritis Rheum; 2020 Oct; 50(5):963-967. PubMed ID: 32906032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.